CASI Pharmaceuticals
CASI
#8753
Rank
C$0.11 B
Marketcap
$7.47
Share price
-7.55%
Change (1 day)
114.81%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -C$36.41 M

According to CASI Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$36.51 M. In 2023 the company made an earning of -C$35.78 M an increase over its 2022 earnings that were of -C$50.78 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$36.41 M1.79%
2023 -C$35.78 M-29.55%
2022 -C$50.78 M4.43%
2021 -C$48.62 M-24.56%
2020 -C$64.45 M4.74%
2019 -C$61.53 M65.13%
2018 -C$37.27 M155.07%
2017 -C$14.61 M13.93%
2016 -C$12.83 M31.18%
2015 -C$9.78 M-72.5%
2014 -C$35.55 M356.62%
2013 -C$7.79 M-60.55%
2012 -C$19.73 M218.41%
2011 -C$6.2 M0.74%
2010 -C$6.16 M-32.54%
2009 -C$9.12 M-66.98%
2008 -C$27.62 M-14.22%
2007 -C$32.19 M7.04%
2006 -C$30.08 M27.95%
2005 -C$23.51 M4.51%
2004 -C$22.49 M-15.84%
2003 -C$26.73 M-55.29%
2002 -C$59.77 M-34.05%
2001 -C$90.63 M31.73%
2000 -C$68.8 M31.56%
1999 -C$52.3 M145.56%
1998 -C$21.3 M76.4%
1997 -C$12.08 M36.92%
1996 -C$8.82 M